No products in the cart.

Description
PRODUCT DESCRIPTION:
Medroxyprogesterone Acetate is a long-acting progestin widely used in reproductive health for contraception and in the management of various hormone-sensitive conditions.
The 150 MG/ML depot formulation is designed for intramuscular injection every 3 months, providing a reliable and reversible form of birth control.
This formulation is also used in specific gynecological disorders, endometriosis, and adjunctively in hormone-responsive cancers under specialist supervision. Manufactured in GMP-certified facilities, it offers high purity, prolonged action, and consistent clinical performance.
Formulation & Presentation:
- Dosage Form: Injectable Solution
- Presentation: Sterile, single-use ampoule or vial (customizable as per market demand)
- Available Strengths: 150 MG/ML
- Route of Administration: Intramuscular Only (IM) or as per clinical indication and severity (As per physician’s discretion or decision)
Therapeutic Indications:
- Long-acting contraception for women
- Management of endometriosis-related pain
- Treatment of secondary amenorrhea
- Adjunct therapy in endometrial or renal carcinoma (where clinically indicated)
Side Effects:
- COMMON:
- Weight gain
- Menstrual irregularities or delayed return to fertility
- Headache
- Breast tenderness
- SERIOUS (RARE):
- Decreased bone mineral density with long-term use
- Mood disorders or depression
- Allergic reactions
- Thromboembolic events (extremely rare)
- PRECAUTIONS:
- Not recommended for women with active thromboembolic disorders or hormone-sensitive malignancies (unless under specialist guidance)
- Prolonged use may affect bone density; consider DEXA scan monitoring
- Not recommended as first-line therapy in adolescents for contraception due to bone health concerns
- Should be administered under medical supervision with clear counseling on delayed return to fertility
Be the first to review “Medroxyprogesterone Acetate Injection 150 MG/ML”
TECHNICAL INFORMATION
Product Specifications:
- HSN Code: To be assigned per international classification standards & import jurisdiction
- Weight: Approx. 40g per Carton (With Packaging)
- Dimensions: (15x1x8 CMS)
- Shelf Life (Subject To Country Specific Guidelines): 2 to 3 years under recommended storage conditions from date of manufacture or as per label specifications
- Storage: Oil-based injectable solution requiring cold-chain logistics (if specified by packaging). Protect from moisture and direct sunlight. The solution should be used strictly as per label guidelines.
Regulatory Status & Supply Information:
- Regulatory Status: WHO-GMP Complaint Manufacturing. Further certifications available on request
- Exports Ready Dossiers: Dossier Available (CTD/eCTD formats)
- Stability: Compliant
- MOQ: Negotiable. Based on market & registration status
- Export Options: Available for private label, institutional supply, or branded export
Who Should Source This Product?
- Medroxyprogesterone Acetate Injection 150 MG/ML is ideal for public health departments, family planning programs, government tenders, NGOs, and women’s health clinics focused on accessible, long-acting contraceptive options.
- It is particularly relevant in Africa, Southeast Asia, Latin America, and other regions where injectable birth control is preferred for population-level reproductive health strategies.
Why Source from PHARMET?
- Single-window sourcing for diverse pharma needs
- Export-ready documentation & regulatory support
- Adaptable documentation support for effective registration
- Trusted consortium network, simplifying India’s complex pharma supply chain
- Multiple approved manufacturers for best fit in import country
- Network of audited, compliant manufacturers across India
- Customizable & flexible branding, packaging & formulation options
- End-to-end logistics flexibility & support
- Deep expertise in exporting specialty injectables & all products
CONTACT DETAILS:
- E-MAIL: hello@pharmet.io
- Phone/WhatsApp Number: +91 9999091881
- Website: www.pharmet.io
Reviews
There are no reviews yet.